These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21153531)

  • 21. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study.
    Bonora E; Kiechl S; Oberhollenzer F; Egger G; Bonadonna RC; Muggeo M; Willeit J
    Diabetologia; 2000 Feb; 43(2):156-64. PubMed ID: 10753036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of depressive symptoms with impaired glucose regulation, screen-detected, and previously known type 2 diabetes: findings from the Finnish D2D Survey.
    Mäntyselkä P; Korniloff K; Saaristo T; Koponen H; Eriksson J; Puolijoki H; Timonen M; Sundvall J; Kautiainen H; Vanhala M
    Diabetes Care; 2011 Jan; 34(1):71-6. PubMed ID: 20929992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.
    Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
    Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures.
    Chen L; Magliano DJ; Balkau B; Colagiuri S; Zimmet PZ; Tonkin AM; Mitchell P; Phillips PJ; Shaw JE
    Med J Aust; 2010 Feb; 192(4):197-202. PubMed ID: 20170456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive drugs as predictors of type 2 diabetes among subjects with impaired glucose tolerance.
    Rajala U; Qiao Q; Laakso M; Keinänen-Kiukaanniemi S
    Diabetes Res Clin Pract; 2000 Dec; 50(3):231-9. PubMed ID: 11106838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes.
    Tankova T; Chakarova N; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2011 Apr; 92(1):46-52. PubMed ID: 21242013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimates.
    Brodovicz KG; Dekker JM; Rijkelijkhuizen JM; Rhodes T; Mari A; Alssema M; Nijpels G; Williams-Herman DE; Girman CJ
    Diabet Med; 2011 Sep; 28(9):1078-81. PubMed ID: 21843304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
    Harati H; Hadaegh F; Tohidi M; Azizi F
    Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcohol consumption, Type 2 diabetes mellitus and impaired glucose tolerance in middle-aged Swedish men.
    Carlsson S; Hammar N; Efendic S; Persson PG; Ostenson CG; Grill V
    Diabet Med; 2000 Nov; 17(11):776-81. PubMed ID: 11131102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A former career as a male elite athlete--does it protect against type 2 diabetes in later life?
    Laine MK; Eriksson JG; Kujala UM; Wasenius NS; Kaprio J; Bäckmand HM; Peltonen M; Mertsalmi TH; Sarna S
    Diabetologia; 2014 Feb; 57(2):270-4. PubMed ID: 24257894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.
    Wang J; Stancáková A; Kuusisto J; Laakso M
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3858-62. PubMed ID: 20463095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance.
    Liu M; Pan C; Jin M
    Diabetes Technol Ther; 2011 May; 13(5):501-7. PubMed ID: 21406016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of antenatal clinical factors for prediction of postpartum outcomes in women with gestational diabetes mellitus (GDM).
    Ingram ER; Robertson IK; Ogden KJ; Dennis AE; Campbell JE; Corbould AM
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):272-279. PubMed ID: 27549600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the utility of self-reported questionnaire data to screen for dysglycemia in young adults: Findings from the US National Health and Nutrition Examination Survey.
    Srugo SA; de Groh M; Jiang Y; Morrison HI; Villeneuve PJ
    Prev Med; 2019 Mar; 120():50-59. PubMed ID: 30639079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.
    Schwarz PE; Li J; Reimann M; Schutte AE; Bergmann A; Hanefeld M; Bornstein SR; Schulze J; Tuomilehto J; Lindström J
    J Clin Endocrinol Metab; 2009 Mar; 94(3):920-6. PubMed ID: 19106274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population.
    Lotfaliany M; Hadaegh F; Asgari S; Mansournia MA; Azizi F; Oldenburg B; Khalili D
    Arch Iran Med; 2019 Mar; 22(3):116-124. PubMed ID: 31029067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.
    Cameron AJ; Magliano DJ; Zimmet PZ; Welborn TA; Colagiuri S; Tonkin AM; Shaw JE
    J Intern Med; 2008 Aug; 264(2):177-86. PubMed ID: 18298479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting.
    Gray LJ; Taub NA; Khunti K; Gardiner E; Hiles S; Webb DR; Srinivasan BT; Davies MJ
    Diabet Med; 2010 Aug; 27(8):887-95. PubMed ID: 20653746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.